Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Rating)’s stock price dropped 1.8% during mid-day trading on Friday . The stock traded as low as $6.09 and last traded at $6.09. Approximately 8,000 shares traded hands during mid-day trading, an increase of 641% from the average daily volume of 1,080 shares. The stock had previously closed […]
Shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 675,000 shares, a drop of 25.5% from the March 15th total of 906,400 shares. Based on an average daily volume of 161,500 shares, the days-to-cover ratio is […]
StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a report issued on Friday morning. The firm issued a hold rating on the stock. China Pharma Stock Down 2.6 % China Pharma stock opened at $0.34 on Friday. The business has a 50-day simple moving average of $0.26 and a two-hundred […]
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Rating) Director Robert Lorne Hopfner purchased 344,592 shares of the business’s stock in a transaction on Wednesday, March 29th. The stock was purchased at an average cost of $4.54 per share, with a total value of $1,564,447.68. Following the acquisition, the director now owns 3,213,586 shares in the company, […]